The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
600 jobs Number of planned job creations
Announcement Date
19 September 2009
Employment effect (start)
1 September 2009
Foreseen end date
31 December 2009
Description
The pharmaceutical company Glaxo Smith Kline (GSK) is about to recruit 600 new workers on its Belgian sites. Because GSK has been chosen to manufacture the vaccine for the influenza virus A/H1NI, the company needs more graduates in chemistry and biology.
Sources
19 September 2009: La Dernière Heure
Citation
Eurofound (2009), Glaxo Smith Kline, Business expansion in Belgium, factsheet number 69574, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/69574.